1. OC-0280 ReRT with bevacizumab is related to lower rate of radionecrosis as reRT alone for recurrent glioma. (April 2019) Authors: Fleischmann, D.; Jenn, J.; Corradini, S.; Ruf, V.; Forbrig, R.; Unterrainer, M.; Thon, N.; Kreth, F.W.; Belka, C.; Niyazi, M. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗